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Abstract.  Recycling of synaptophysin (p38),  a  synap- 
tic vesicle integral membrane protein, was studied by 
the use of antisera raised against the protein purified 
from frog brain.  When frog cutaneous pectoris mus- 
cles were fixed at rest, a  bright,  specific immunofluo- 
rescent signal was observed in nerve-terminal regions 
only if their plasma membranes had been previously 
permeabilized. When muscles were fixed after they 
had been treated for 1 h  with a  low dose of ct-latro- 
toxin in Ca2÷-free medium, an equally intense fluores- 
cence could be observed without previous permeabil- 
ization. Under this condition, ~t-latrotoxin depletes 
nerve terminals of their quantal store of acetylcholine 
and of synaptic vesicles. These results indicate that fu- 
sion of synaptic vesicles leads to the exposure of 
intravesicular antigenic determinants of synaptophysin 
on the outer surface of the axolemma, and provide di- 
rect support for the vesicle hypothesis of neurotrans- 
mitter release. After 1 h treatment with the same dose 
of a-latrotoxin in the presence of 1.8 mM extracellular 
Ca  2+, immunofluorescent images were obtained only 
after permeabilization with detergents. Under this con- 
dition, the vesicle population was maintained by an ac- 
tive process of recycling and more than two times the 
initial store of quanta were secreted.  Thus, despite the 
active turnover of synaptic vesicles and of quanta of 
neurotransmitter, no extensive intermixing occurs be- 
tween components of the vesicle and presynaptic 
plasma membrane. 
T 
he fusion of the synaptic vesicle membrane with the 
axolemma leads to neurotransmitter release by exocy- 
tosis. This process is followed by an active process of 
membrane retrieval that tends to maintain the population of 
synaptic vesicles constant and to prevent an increase in the 
surface area of the terminal. Two different models have been 
proposed to account for the functional recovery of synaptic 
vesicles from the nerve-terminal plasma membrane, mainly 
on the basis of experimental evidence obtained at the frog 
neuromuscular junction. The first model postulates a com- 
plete collapse of the vesicle membrane into the axolemma, 
followed by intermixing of molecular components and mem- 
brane recovery via coated vesicles (Heuser and Reese, 1973; 
Miller and Heuser, 1984).  Alternatively, the opening of the 
fused vesicle may be a  very transient process,  the vesicle 
membrane being removed directly, without intermixing of 
membrane components (Ceccarelli et al.,  1973;  Ceccarelli 
and Hurlbut, 1980a;  Meldolesi and Ceccarelli, 1981; Torri- 
Tarelli  et al.,  1987).  According to the latter hypothesis, a 
coated-vesicle mechanism is not required for the retrieval of 
the synaptic vesicle membrane.  Efforts to distinguish be- 
tween these two possibilities have so far been hampered by 
the lack of suitable markers for the synaptic vesicle mem- 
brane. 
Recently synaptophysin, an integral membrane protein of 
the  synaptic vesicle,  has  been  purified from mammalian 
brain and localized in peripheral and central nerve terminals 
as well as in neuroendocrine cells (Jahn et al., 1985; Wieden- 
mann and Franke, 1985; Wiedenmann et al., 1986; Navone 
et al., 1986). In this report, we describe studies of the recy- 
cling of synaptic vesicles at the frog neuromuscular junction 
using antibodies raised against purified frog brain synap- 
tophysin.  Quantal  secretion  of acetylcholine  (ACh) ~ has 
been stimulated using alpha-latrotoxin (ct-LTx), the purified 
active component of black widow spider venom, which is 
known to induce a massive release of neurotransmitter in- 
dependently of extracellular Ca  2÷  (Frontali  et  al.,  1976; 
Hurlbut  and  Ceccarelli,  1979;  Ceccarelli  and  Hurlbut, 
1980b; Meldolesi et al., 1986). The low doses of et-LTx used 
in  this  study  stimulate  neurotransmitter  release  in  both 
Ca2÷-free  and  Ca2+-containing  media.  However,  in  Ca  2+- 
1.  Abbreviations used in this paper:  ACh, acetylcholine; ¢t-LTx,  ct-latro- 
toxin; m.e.p.p., miniature endplate potential. 
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by a rapid depletion of synaptic vesicles because of a block 
of endocytosis, whereas in Ca2+-containing  medium exocy- 
tosis is sustained for longer periods of time by an active pro- 
cess of membrane recycling, ct-LTx is therefore a useful tool 
for studying the redistribution of vesicular antigens during 
the exo-endocytotic cycle. 
Materials and Methods 
Materials 
Materials were purchased from the sources indicated: 2-in-long frogs (Rana 
pipiens),  from Connecticut Valley  Biological Supply Co.,  Southampton, 
MA; phenylmethylsulfonyl fluoride (PMSF),  sperm whale skeletal muscle 
myoglobin type II, and horseradish peroxidase type VI from Sigma Chemi- 
cal Co., St. Louis, MO; pepstatin from Chemicon, El Segundo, CA; aproti- 
nin (Trasylol) from Bayer, Leverkusen, FRG; CNBr-activated Sepharose 4B 
(Pharmacia Fine Chemicals, Uppsala, Sweden); complete Freund's adjuvant 
from Calbiochem-Behring Corp., La Jolla, CA; nitrocellulose membranes 
(pore size, 0.22 Ixm) from Schleicher &  Schuell, Keene, NH;  125I-Protein 
A from New England Nuclear, Boston, MA. Rhodamine-conjugated goat 
anti-rabbit IgGs, purchased from Cooper Biomedicals, Malvern, PA, were 
hound onto a  Sephadex DE52  column (Pharmacia Fine Chemicals) and 
eluted with  100  mM NaCI/10 mM sodium phosphate buffer, pH 7.3.  All 
other reagents were of analytical grade. Rat brain synaptophysin  and mAbs 
were prepared as described (Jahn et al.,  1985). 
Purification of  Synaptophysin from Frog  Brain 
Synaptophysin was purified from frog brain using a modification of the pro- 
cedure described for the purification of rat synaptophysin (Navone et al., 
1986). Briefly,  120 frogs were decapitated, and the brains were removed and 
homogenized with a glass-Teflon homogenizer in 90 ml of an ice-cold solu- 
tion containing 0.25 M sucrose, 5 mM Hepes-NaOH, pH 7.4, 1 mM EDTA, 
0.1 mM PMSF, 2 I.tg/ml pepstatin, and 1 U/ml aprotinin. The homogenate 
was centrifuged at 800 g for 10 min; the supernatant was saved and the pellet 
was resuspended in 50 ml of the same buffer used for the homogenization 
and was spun again. The combined supernatants were centrifuged for 60 
min at 120,000 g and the resulting pellet was homogenized in 110 ml of so- 
dium PBS,  1% (vol/vol) Triton X-100,  0.1 mM PMSE 2  I.tg/ml pepstatin, 
and 1 U/ml aprotinin. After being stirred on ice for 30 min, the extract was 
centrifuged for 60 min at 120,000 g. The pellet was resuspended in the ex- 
traction medium and the suspension was respun. The combined superna- 
tants were loaded onto a column of activated Sepharose 4B coupled to mAbs 
(C7.2 and C7.3)  against rat brain synaptophysin. The washing and elution 
steps  were  performed  as  described  (Navone et  al.,  1986),  to  yield the 
purified frog brain synaptophysin. 
Generation of  Antisera 
Purified frog brain synaptophysin ("~3 mg) was boiled for 2  min in stop- 
solution (3 % sodium dodecyl sulfate [SDS], 5 % [vol/vol] I~-mercaptoetha- 
nol,  1 mM EDTA, 8%  [wt/vol] sucrose, 62 mM Tris-HCl [pH 6.7])  and 
loaded on an SDS-10% polyacrylamide preparative gel. After electrophore- 
sis, the unfixed gel was soaked for ~10 rain in 4 M sodium acetate (Higgins 
and Dahmus, 1979). The visualized protein band was cut out and the ex- 
cised gel piece was homogenized, emulsified in complete Freund's adjuvant, 
and injected intradermally at multiple sites into New Zealand female rab- 
bits. After the initial injection, three booster injections (containing one third 
of the original  amount of protein)  were  given at  weekly  intervals.  The 
animals were bled  1 wk after the administration of the final booster. 
Preparation and Pronase Digestion of  a Crude 
Synaptic Vesicle  Fraction  from Frog  Brain 
A  fraction  enriched  in  frog brain  synaptic  vesicles was prepared  by  a 
modification of a new procedure developed for the purification of synaptic 
vesicles from rat brain (Hell,  Maycox, Stadler,  and Jahn,  manuscript in 
preparation),  l0 frog brains (total  wet weight: 0.5 g) were quickly frozen 
in liquid nitrogen and crushed into powder using a cold steel mortar. All 
the following steps were carried out at 10°C. The powder was quickly resus- 
pended  in  10 ml of 0.32  M  sucrose,  1 mM EGTA,  1  p.g/ml  pepstatin, 
0.2 mM PMSF, and 10 mM Tris-Cl (pH 7.4 at 4°C) and homogenized with 
10 strokes (1,000 rpm) in a tight-fitting glass-Teflon homogenizer. The ho- 
mogenate was centrifuged at 47,000 gma~ for 10 min. The resulting super- 
natant was layered over a  5-ml sucrose cushion (0.6  M  sucrose,  1 mM 
EGTA,  1 lag/ml pepstatin A, 0.2 mM PMSF, and 10 mM Tris-C1, pH 7.4) 
and centrifuged for 2 h at 260,000 gmax in a rotor (Ti 60; Beckman Instru- 
ments, Fullerton, CA). The resulting pellet was resuspended in a small vol- 
ume of 150  mM NaC1,  5  mM Hepes-NaOH, pH 7.4,  and subjected to 
pronase digestion. Digestion of the vesicles by pronase was performed for 
different periods of time (up to 60 min) as described (Jahn et al.,  1985), 
using 1 mg/ml vesicle protein and 0.1  mg/ml pronase.  At different time 
points, aliquots were removed and either solubilized in stop solution, boiled 
for 2 min and used for electrophoresis and immunoblotting, or negatively 
stained with  1%  uranyl acetate and observed in the electron microscope. 
Electrophoresis and Immunoblotting 
Protein samples, solubilized in stop-solution, were boiled  for 2  min and 
separated on SDS-10% polyacrylamide gels using the discontinuous system 
described by  Laemmli (Laemmli,  1970).  After electrophoresis, the gels 
were either stained with Coomassie Brilliant Blue or transferred to nitrocel- 
lulose membrane sheets (0.22 ~tm pore size) as described (Towbin et al., 
1979).  The protein blots were processed for synaptophysin immunoreac- 
tivity either by an immunoperoxidase procedure (Jahn et al.,  1985)  or by 
using ~25I-labeled protein A.  In the latter case, immunolabeling was per- 
formed as follows: (a) incubation for  1 h in PBS, 5%  (wt/vol) nonfat dry 
milk, 0.1% Triton X-100; (b) incubation for 2 h in the same solution contain- 
ing anti-synaptophysin antiserum (1:500-1:3,000);  (c)  washing with  five 
changes of PBS, 0.1% Triton X-100 over a total period of 30 rain; (d) incu- 
bation for 30 min in PBS, 5%  nonfat dry milk, 0.1% Triton-X-100; (e) in- 
cubation for 45  min in the same solution containing ~25I-protein A  (200 
cpm/I.tl);  and  (f)  extensive washing with  several changes of PBS,  0.1% 
Triton-X-100 (3 h to overnight). 
Electrophysiology 
Cutaneous pectoris nerve-muscle preparations were dissected from frogs, 
mounted in Lucite chambers, and bathed in standard Ringer's solution con- 
taining:  Na ÷,  116;  K ÷,  2.1;  Ca  2÷,  1.8; CI  ,  117; HPO42  ,  2;  H2PO4  , 
1 mM; pH 7.0. When the ionic composition of the bathing solution was to 
be changed, the concentration of NaCI was modified to maintain the tonicity 
constant, ct-LTx (a gift from Dr. J. Meldolesi, University of Milan, Milan, 
Italy) was stored at -70°C and its activity was tested as previously described 
(Ceccarelli  and  Hurlbut,  1980b).  Immediately  before  use,  ot-LTx  was 
diluted to a  final concentration of 0.2-0.4  ~g/ml in either 4  mM Mg  2÷- 
standard Ringer's solution or Ca2÷-free (4 mM Mg  2÷ and  1 mM EGTA) 
Ringer's solution; the recording chamber was drained and refilled with 2.5 
ml of this solution. Paired muscles from individual frogs were used in all 
experiments in which the effects of Ca2+-free and Ca2+-containing solu- 
tions were compared. All experiments were performed at room tempera- 
ture. Endplate regions were impaled with glass microelectrodes filled with 
3  M  KCI  (resistance  10-30 mf~) and membrane potential  was recorded 
through a conventional high-impedance preamplifier. The amplified signal 
was saved on tape both as a high gain AC record (band width 0.3-1,250 Hz) 
and as a low gain DC record (band width 1,250 Hz), using a tape recorder 
(Racal 4DS; Rank Precision Ltd., London, UK) for subsequent acquisition 
and analysis by a computer (Micro-PDP  11/73;  Digital Equipment Corp., 
Maynard, MA). 
Fluctuation Analysis 
Intense asynchronous quantal secretion of ACh generates, at postjunctional 
sites, a random signal that can be studied by fluctuation analysis (Segal et 
al.,  1985).  This analysis allows the measurement of the rate of quantal 
secretion (and therefore of exocytosis) when its value is high, so that single 
events cannot be distinguished individually. The stochastic procedure used 
is  insensitive to  changes in  membrane potential  that  may occur during 
prolonged experiments and yields reliable estimates of the time course, am- 
plitude, and rate of occurrence of miniature endplate potentials (m.e.p.p.s) 
even in the presence of nonlinear summation, nonhomogeneous  amplitudes, 
and rapid variations of m.e.p.p, rate and amplitude (Fesce et al., 1986). We 
summarize here only the main features of the procedure.  The entire time 
course of the m.e.p.p.s is accurately described by the product of an am- 
plitude  factor  (h)  times a  dimensionless waveform factor,  w(t)  =  e-'/°~ 
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power spectra of the voltage signal recorded at the endplate, computed at 
intervals of a few minutes, m.e.p.p, rate and the amplitude factor "h" were 
measured from the variance and skew of endplate noise (Segal et al., 1985), 
computed on successive 10-s records and corrected for nonlinear summa- 
tion of m.e.p.p.s. The following equations were used: 
m.e.p.p, rate  =  VAR3/SKEW -'  ×  L:/I:  3  (1) 
h  =  SKEW/VAR  ×  I~/I~  (2) 
where  I~  and  13  represent  the  integrals  of the  square  and  the cube  of 
m.e.p.p, waveform, respectively. A high-pass resistance capacitance filter 
with a 2-ms time constant was used to eliminate contributions of nonstation- 
arity to the variance (VAR) and skew (SKEW) prominent especially in the 
bursting pattern of secretion induced by  ct-LTx in the presence of Ca  :+ 
(Fesce et al.,  1986). 
Immunocytochemistry 
For frog nerve-muscle preparations, after intracellular  recording of m.e.p.p.s, 
the muscles were fixed for 1 h in the recording chamber. In preliminary ex- 
periments, when antibodies were applied to resting preparations fixed with 
4%  formaldehyde, 0.1  M  sodium phosphate buffer,  pH 7.4,  occasionally 
patches of fluorescence could be observed in nerve-terminal branches even 
without previous permeabilization. We attributed this observation to partial 
permeabilization of the axolemma induced by incomplete membrane fixa- 
tion and/or by the hypertonicity of the fixative  solution.  We  thus tested 
different fixative solutions and found that the mixture of 0.25% glutaralde- 
hyde with 1% formaldehyde in 0.1 M sodium phosphate buffer, pH 7.4, rep- 
resented a good compromise between preserving membrane integrity and 
retaining  adequate  immunoreactivity.  After  fixation,  the  muscles  were 
washed with 0.1 M sodium phosphate buffer (pH 7.4) and the muscle fibers 
were then dissociated under  a  dissecting microscope as  previously  de- 
scribed (Valtorta  et al.,  1984).  Single fibers were transferred to test tubes 
and processed for synaptophysin immunoreactivity through the following 
steps (at room temperature, unless otherwise indicated): (a) washing for 20 
min in0.1  M glycine-NaOH, pH 7.4;  (b) washing for 10 min in 0.1  M so- 
dium phosphate buffer,  pH 7.4; (c) incubation for 3 h with rabbit anti-syn- 
aptophysin antiserum or preimmune serum diluted (1:40-1:100)  with 0.5 M 
NaC1,  17% normal goat serum, and 20 mM sodium phosphate buffer, pH 
7.4;  (d) several changes of 0.5 M  NaCI, 20 mM sodium phosphate buffer, 
pH 7.4; (e) 1 h incubation with rhodamine-conjugated goat anti-rabbit IgGs 
diluted  1:20 with the same solution used  for the first antiserum supple- 
mented with 0.1% Triton X-100; and (f) overnight washing at 4°C with 0.5 
M NaCI, 20 mM sodium phosphate buffer (pH 7.4),  0.1% Triton X-100. In 
the detergent-treated samples, 0.1% Triton X-100 was included in the solu- 
tions during the incubation with the primary antiserum and during all the 
washing steps. In some experiments, after the final  wash, ACh receptors 
were labeled by incubating the muscle fibers either for 3 h at room tempera- 
ture or overnight at 4°C with fluorescein-conjugated ~t-bungarotoxin  (di- 
luted 1:1,000 with the same buffer used for the dilution of the antibodies), 
followed by washing with several changes of 0.5  M NaCI, 20 mM sodium 
phosphate buffer (pH Z4) and 0.1%  Triton X-100. 
For frozen sections from rat brain, ~10-1am-thick frozen sections from 
different regions of rat brain were prepared and immunostained as previ- 
ously described (De Camilli et al.,  1983). 
Electron Microscopy 
Muscles to be processed for electron microscopy were fixed in the recording 
chamber for 1 h at 4°C with 2% OsO4 in Oil M sodium phosphate buffer, 
pH 7.4.  Small specimens of tissue containing endplate regions were dis- 
sected out, dehydrated, and flat embedded in Epon 812 according to stan- 
dard procedures (Ceccarelli et al.,  1973).  Silver-gray sections were cut on 
a Reichert-Jung UItracut microtome, double-stained with uranyl acetate and 
lead citrate, and examined in either a H-600 or a H-7000 Hitachi electron 
microscope. In some experiments, 1.6% (wt/vol) horseradish peroxidase (or 
1.6%  horseradish peroxidase, 0.5%  sperm whale myoglobin) was added 
"~30  rain before the addition of ct-LTx. This preineubation did not affect 
m.e.p.p, frequency. After 1 h in ¢t-LTx and extracellular tracers, these mus- 
cles  were  fixed  for  1  h  with  1%  glutaraldehyde,  0.25%  formaldehyde 
(freshly  prepared  from  paraformaldehyde)  in  0.1  M  sodium  phosphate 
buffer, pH 7.4.  Small pieces of muscles were treated to reveal peroxidase 
activity and further processed as previously described (Graham and Kar- 
nowsky,  1966;  Ceccarelli and Hurlbut,  1980b). 
Protein Determinations 
Protein was determined by the method of Bradford (1976), using the protein 
assay  reagent (Bio-Rad  Laboratories,  Richmond, CA) and  lgGs as stan- 
dards. 
Results 
Antisera to Frog Synaptophysin 
Preliminary experiments performed with both monoclonal 
and  serum  antibodies  generated against  rat  synaptophysin 
demonstrated the presence in the frog of a  protein cross- 
reacting with antibodies to mammalian synaptophysin (Jahn 
et al.,  1986).  However, the degree of cross-reactivity was 
low, and attempts to use these antibodies for the immunocy- 
tochemical localization of synaptophysin in the frog were un- 
successful.  We  therefore decided  to  purify  synaptophysin 
from frog brain and to use it to raise antibodies. We followed 
a modification of the procedure described by Navone et al. 
(1986) to purify synaptophysin from rat brain; for the affin- 
ity-column step, we took advantage of the cross-reactivity to- 
wards the frog of the mAb against the rat protein. By this pro- 
cedure, we obtained a material that appeared to consist of a 
single polypeptide when  analyzed by Coomassie  Brilliant 
Blue staining of an SDS-10%  polyacrylamide gel (Fig.  1). 
This  polypeptide was  specifically recognized on blots  by 
antibodies against rat brain synaptophysin (data not shown). 
The antisera  raised  against  the  purified frog protein spe- 
cifically recognized synaptophysin on immunoblots of pro- 
teins from frog brain homogenates (Fig. 2). Frog brain syn- 
aptophysin  appears  to  have  a  slightly  higher  molecular 
weight than the mammalian homologue and like the mam- 
malian protein (Wiedenmann et al.,  1985), it can also exist 
in a dimeric form (Fig. 2, lane b). The ratio between the di- 
meric  and  the  monomeric  form  was  dependent  on  the 
amount of reducing agent present in the buffer used for the 
solubilization of the sample.  As can be seen in Fig. 2, the 
affinity of the antisera for the antigen was  much higher in 
frog than in rat. Nevertheless, bright nerve-terminal staining 
could be seen when antisera against frog synaptophysin were 
Figure  1.  Purification  of synap- 
tophysin from frog brain. Lane a, 
rat forebrain homogenate (50 Ixg); 
lane b, purified rat brain synapto- 
physin (2  ~tg);  lane c,  frog brain 
homogenate (50 ~tg); lane d, frog 
brain synaptophysin (2  ~tg).  Mo- 
lecular weight standards: 94,000; 
68,000;  45,000;  36,000;  29,000; 
and  24,000.  The  samples  were 
separated  on an SDS-10%  poly- 
acrylamide  gel  and  stained  with 
Coomassie Brilliant Blue. 
Valtorta  et al. Recycling of Synaptophysin (p38)  2719 Figure 2.  Autoradiograph of an immu- 
noblot  showing the  specificity of the 
antiserum  against frog  synaptophysin. 
The protein samples were separated on 
an  SDS-t0%  polyacrylamide  gel  and 
transferred  to a nitrocellulose  membrane. 
The blot was labeled with anti-frog syn- 
aptophysin antiserum (dilution 1: 3,000), 
followed by ~25I-Protein  A. (lane a) Frog 
brain homogenate, 10 lag; (lane b) puri- 
fied frog brain  synaptophysin, 0.5  gg; 
(lane c) rat forebrain total homogenate, 
10 lag; and (lane d) purified rat brain 
synaptophysin, 1 lag. Arrow, the single 
band of immunoreactivity correspond- 
ing to the synaptophysin  band in the frog 
brain total homogenate. The upper band 
in  lane  b  corresponds  to  the  dimeric 
form of synaptophysin. 
used in immunofluorescence experiments on frozen sections 
of rat brain (Fig.  3). 
For our imunofluorescence experiments (see below),  it 
was important to use an antiserum recognizing intravesicular 
epitopes, which are expected to become exposed to the extra- 
cellular space upon fusion of the vesicle membrane with the 
axolemma. If this were the case, (an) immunoreactive frag- 
ment(s) of synaptophysin should be found in synaptic vesi- 
cles subjected to proteolytic digestion of the cytoplasmic do- 
main.  A  fragment generated by pronase digestion of intact 
synaptic vesicles was  indeed recognized by the antiserum 
against  frog synaptophysin (Fig.  4).  These findings are in 
agreement with previous findings obtained in rat brain syn- 
aptic vesicles, in which a major 27-kD proteolytic fragment 
of synaptophysin is found (Jahn et al.,  1985). 
Immunolocalization of  Synaptophysin 
in Resting Terminals 
Frog neuromuscular preparations fixed at rest were exposed 
to anti-frog synaptophysin antisera in the presence of deter- 
gent and subsequently exposed to a rhodaminated secondary 
antibody. The distribution ofimmunofluorescence for synap- 
tophysin (Fig.  5  b) was  similar to the distribution of ACh 
receptors  as  revealed  by  fluoresceinated  ct-bungarotoxin 
(Fig. 5 a), indicating that synaptophysin was highly concen- 
trated only in the nerve-terminal region. Indeed, the branch- 
ing patterns revealed by the two stainings were virtually su- 
perimposable. The individual terminal branches revealed by 
antisynaptophysin  immunostaining  often  exhibited  a  seg- 
mented pattern of immunofluorescence. This pattern might 
be due to a higher concentration of synaptic vesicles in the 
region of the nerve terminals between adjacent Schwann cell 
invaginations  (Valtorta  et  al.,  1988).  When  preparations 
were similarly exposed to antisynaptophysin antisera in the 
absence of detergent (so that intraterminal components were 
not accessible to antibodies), no specific immunofluorescence 
was detected (Fig. 5 d) and neuromuscular junction regions 
Figure 3. Light micrographs showing the distribution of immunofluorescence for synaptophysin in two regions of rat brain. Frozen sections 
(,~10  lam thick) were stained by immunofluorescence using antiserum against frog brain synaptophysin (1:100) and rhodaminated goat 
anti-rabbit IgGs (1:50). (a) CA3-CA4 region of hippocampus; (b) deep mesencephalic nucleus. Immunoreactivity is specifically localized 
to regions containing nerve terminals. Bars, 50 lam. 
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aptic vesicle fraction purified from frog brain and  subjected to 
pronase treatment for 60 min. (b) Identification of an intravesicular 
fragment recognized by antifrog synaptophysin  antiserum. A crude 
synaptic vesicle fraction purified from frog brain was subjected to 
pronase digestion. The digestion was either immediately stopped 
(left lane) or continued for 60 min (right lane). Proteins were sepa- 
rated by SDS-PAGE, transferred to a  nitrocellulose membrane, 
incubated with antiserum against frog synaptophysin, and the im- 
munoreactive bands were visualized by immunoperoxidase. The 
antiserum recognized both the intact protein and a fragment gener- 
ated by proteolytic digestion (arrow). Bar, 0.5 ~m. 
could be identified only by fluoresceinated ct-bungarotoxin 
(Fig. 5 c). These findings are consistent with the notion that 
synaptophysin is an integral membrane protein of synaptic 
vesicles,  which  in  resting  preparations  is  expected to  be 
confined within the nerve-terminal axoplasm and not to be 
exposed to the extracellular space. 
Effects of a-LTx in Ca2÷-free  and 
Cae÷-containing  Medium 
To study the redistribution of synaptophysin at neuromuscu- 
lar junctions upon exocytosis we have stimulated secretion 
with a-LTx. Low doses of toxin exert different effects on the 
exo-endocytotic process when applied in the absence rather 
than in the presence of extracellular calcium. In the absence 
of extracellular calcium (4 mM Mg2÷), 0.2 ~tg/ml ~t-LTx in- 
duced an enormous but transient discharge of quanta of ACh 
accompanied by complete depletion of synaptic vesicles that 
was achieved within  1 h,  and by enlargement of the trans- 
verse dimension of nerve-terminal branches (Fig. 6 a). A to- 
tal of 830,000  +_  120,000  quanta were secreted under this 
condition, as measured by fluctuation analysis applied to in- 
tracellular endplate recordings (Fig. 7 a). This figure is in 
agreement  with  previous  estimates  of the  initial  store  of 
quanta and vesicles present at rest in frog motor nerve termi- 
nals (Ceccarelli and Hurlbut,  1975;  Haimann et al.,  1985; 
Fesce et al.,  1986;  Ceccarelli et al.,  1988).  Experiments 
with  the  extracellular tracers  horseradish  peroxidase and 
myoglobin showed that, under these conditions, no extracel- 
lular tracer reaction products could be detected inside the 
nerve terminal, indicating that the plasma membrane was not 
grossly  permeabilized (Fig.  6  b).  These findings  confirm 
previous findings obtained with crude homogenates of black 
widow spider venom (Ceccarelli and Hurlbut, 1980b).  When 
the same concentration of toxin was applied in the presence 
of 1.8 mM Ca  2+ and 4 mM Mg  2÷, the quantal secretion rate 
remained  high  and  constant  for at  least  1  h,  1.8  million 
quanta being  secreted in that time (Fig.  7  b),  and  neither 
marked depletion nor swelling of the nerve terminals was ob- 
served (Fig. 6 c). In this condition, most of  the synaptic vesi- 
cles were labeled with extracellular tracer reaction product 
(Fig. 6, d and e), indicating that the vesicle population was 
maintained by active membrane recycling. 
lmmunolocalization of  Synaptophysin in 
a-LTx-treated Terminals 
The distribution of synaptophysin in nerve terminals treated 
for 1 h with 0.2 ~tg/ml ct-LTx in Ca2÷-free solution is shown 
in  Fig.  8.  In  contrast to the  situation observed in  control 
preparations (Fig. 5), bright fluorescence staining of nerve 
terminals was present without previous permeabilization of 
the plasma  membrane with detergent.  A  marked  increase 
in the apparent transverse dimension of the nerve terminal 
was  always  observed.  The average transverse dimensions 
(micrometers +  SD) were 2.4 +  0.6 for the control prepara- 
tions and 4.9  +  1.6 for the preparations treated with a-LTx 
in Ca2+-free  medium.  These figures represent an overesti- 
mate of the true diameters, as they include the fluorescence 
halo (Valtorta et al.,  1984) and are reported only to provide 
an estimate of the degree of swelling that occurred in the 
a-LTx-treated preparations. 
When  nerve-muscle preparations  were treated  with the 
same dose of ct-LTx in the presence of extracellular calcium, 
the fluorescent images observed were indistinguishable from 
those observed under resting conditions (Fig. 9). Omission 
of detergent from the solution used for dilution of the anti- 
synaptophysin antisera resulted in the lack of specific stain- 
ing of nerve terminals, which could be identified by double- 
labeling with fluoresceinated a-bungarotoxin. No increase 
in the apparent transverse dimension was observed in the 
presence of calcium (Fig.  9). 
Discussion 
Morphometric analysis of changes in ultrastructure induced 
by prolonged stimulation and the use of extracellular tracers 
to follow the recovery of synaptic vesicle membrane from the 
axolemma have provided evidence for the existence of the 
exo-endocytotic cycle (Heuser and Reese,  1973; Ceccarelli 
et al., 1972; Ceccarelli et al., 1973; Ceccarelli and Hurlbut, 
1980a). However, these approaches cannot be used to study 
the selectivity of endocytosis of vesicle membrane relative to 
components  of the  plasma  membrane.  We  have  now  at- 
tempted to study vesicle membrane movements using specif- 
ic antibodies against a  synaptic vesicle membrane protein, 
synaptophysin, purified from frog brain. 
mAbs to rat synaptophysin were used to affinity purify a 
related  protein  from  frog  brain.  In  SDS-polyacrylamide 
gels,  this protein had a  higher apparent molecular weight 
than the mammalian  homologue.  The slight difference in 
molecular weight might reflect a more general phenomenon, 
since in the frog another synaptic vesicle protein, synapsin 
I, also appears to have a higher molecular weight (Valtorta 
et al.,  1988). In agreement with what has been observed in 
mammals (Wiedenmann and Franke,  1985; Navone et al., 
1986),  in  the  frog  synaptophysin appears  to  consist of a 
Valtorta et al. Recycling of Synaptophysin (p38)  2721 Figure 5. Fluorescence micrographs  of resting neuromuscular  junctions on single muscle fibers teased apart from frog cutaneous pectoris 
muscle. The fixed preparation shown in a and b was treated with 0.1% Triton X-IO0 and double stained with (a) fluoresceinated a-bungaro- 
toxin and with (b) antisynaptophysin antiserum followed by rhodamine-conjugated  goat anti-rabbit  IgGs. Similar patterns of nerve terminal 
The Journal of Cell Biology, Volume 107, 1988  2722 Figure 6. Effects of a-LTx on the ultrastructure  of neuromuscular junctions. (a and b) Electron micrographs of cross-sectioned terminals 
treated  for 1 h with 0.2 lag/ml a-LTx in Ca2+-free solution.  The terminal  branches shown in b come from an experiment in which 1.6% 
horseradish peroxidase  and 0.5 % myoglobin were present.  (c) Electron micrograph from a cross-sectioned terminal  treated  for 1 h with 
the same concentration of a-LTx in Ca2÷-containing Ringer's  solution.  (d and e) Longitudinal  sections  of terminals  treated  as in c in the 
presence of 1.6% horseradish peroxidase.  Notice the normal appearance of the terminal  in c and the depletion  of synaptic  vesicles  and 
the swelling of the terminal  in a and b. In d and e, most of the synaptic vesicles are loaded with horseradish peroxidase  reaction product. 
Bars,  1 ~'n. 
disulfide-linked  homooligomer.  When  tested  by  immuno- 
blotting, the antisera raised against the purified frog protein 
specifically  recognized  synaptophysin from both  frog and 
rat. When tested by immunofluorescence on frozen sections 
from rat brain,  these  antisera  reproduced the fluorescence 
pattern previously described using antisera raised against rat 
synaptophysin (Wiedenmann and Franke,  1985;  Navone et 
al.,  1986).  In immunofluorescence experiments  with  frog 
nerve-muscle preparations, the entire nerve-terminal arbori- 
zation  was  uniformly  decorated  by  these  antisera.  Im- 
munolabeling was highly specific for nerve terminals and no 
fluorescence  was  found  associated  with  other  portions  of 
muscle fibers, with myelinated axons, or with unmyelinated 
preterminal  axons.  The  lack  of immunostaining  observed 
when the antisera  were applied before membrane permea- 
bilization  indicates that synaptophysin was confined within 
the  axoplasm.  Together,  these  findings  are  those  expected 
for  immunostaining  with  antibodies  to  a  synaptic  vesicle 
antigen. 
Antibodies specific to secretory granule membrane com- 
ponents have been previously used in other systems for the 
study of membrane recycling.  Evidence for a  selectivity of 
the retrieval process has been provided in chromaffin cells, 
a widely used model for the study of exocytosis, by the use 
branching are revealed  by the postsynaptic  (a) and presynaptic (b) markers.  The nerve terminal  shown in c and d is from a preparation 
double stained  as in a  and b (c,  ~t-bungarotoxin; d, synaptophysin),  except that no detergent  was used.  In this condition, synaptophysin 
labeling  is undetectable  and the nerve terminal  region can be identified only by the distribution  of a-bungarotoxin labeling.  Bar, 50 Ixm. 
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Figure  7.  Time  course  of 
m.e.p.p, rate ([]) and cumula- 
tive quantal secretion (x) com- 
puted from fluctuation analysis 
of endplate recordings during 
exposure to 0.2  p.g/ml ¢t-LTx 
in  either  Ca~+-free  or  Ca  2÷- 
containing  Ringer's  solution. 
Each  point  is  the  average of 
the corresponding values from 
three  different  experiments. 
m.e.p.p,  rate (s  -~) is given on 
a  logarithmic scale. 
of antisera against glycoprotein III and dopamine-13-hydroxy- 
lase (Patzak et al.,  1984;  Patzak and Winkler,  1986).  In that 
system,  patches  of  immunoreactivity  for  vesicle  antigens 
could be detected on the cell  surface for up to 45  min after 
the end of stimulation.  Several factors can account  for this 
relatively slow recovery process; among them are the kinetic 
properties  of the  exo-endocytotic  cycle  in  that  system,  in 
which the half-life of the fused granules has been estimated 
to be of the order of minutes (von Grafenstein et al.,  1986). 
At the frog neuromuscular junction,  it appears that the half- 
life  for the  fused  vesicle  is  <1  s  (Ceccarelli  et  al.,  1979; 
Ceccarelli  and  Hurlbut,  1980a).  Thus,  when  high  rates  of 
secretion  are  maintained  by  a  balance  between  exocytosis 
and endocytosis, a selective retrieval process would prevent 
the incorporation  of relevant amounts of vesicle membrane 
into the axolemma. A vesicle antigen would be detectable in 
the axolemma only when the rate of exocytosis far exceeded 
the  rate of endocytosis.  Hence,  we studied  the distribution 
of synaptophysin under two extreme conditions:  (a) after in- 
tense quantal secretion in the presence of a block of endocy- 
tosis; and (b) during intense quantal secretion with active re- 
cycling of synaptic  vesicles. 
At the neuromuscular junction,  ~t-LTx is known to induce 
an increase of several orders of magnitude in the rate of oc- 
currence  of m.e.p.p.s  that  ultimately  leads  to  a  complete 
depletion  of quanta  of ACh and of synaptic vesicles.  It has 
been  shown  that  high  doses  of crude  black  widow  spider 
venom  homogenate  cause  depletion  independently  of  the 
Figure 8.  Two examples of fluorescence micrographs showing  synaptophysin  immunoreactivity in neuromuscular junctions treated for 1 h 
with 0.2  p.g/ml ct-LTx in Ca2+-free  Ringer's solution.  No detergent was used.  In this condition,  no permeabilization was necessary to 
reveal synaptophysin immunoreactivity and the nerve terminal branches show a marked increase in their transverse dimension. Bar, 50 p.m. 
The Journal of Cell Biology, Volume 107, 1988  2724 Figure 9.  Fluorescence micrographs of neuromuscular junctions exposed for 1 h to 0.2 I.tg/ml a-LTx in Ca2+-containing Ringer's solution 
and double stained as in Fig. 5. (a and b) Neuromuscular  junction double stained (a, a-bungarotoxin; b, synaptophysin) after permeabiliza- 
tion with 0.1% Triton X-100. No obvious difference can be seen between the synaptophysin immunofluorescence  pattern of this nerve termi- 
nal and that of a nerve terminal fixed at rest (Fig. 5). (c and d) Neuromuscular  junction not treated with detergent. Note that synaptophysin 
immunoreactivity (d) is not revealed without permeabilization, whereas et-bungarotoxin labeling (c) shows the normal appearance of the 
endplate region.  Bar,  50 gtm. 
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are used, a complete depletion can be obtained only in the 
absence of calcium (Ceccarelli and Hurlbut,  1980b). 
In these experiments, low doses of purified ct-LTx, when 
applied  in  Ca2+-free  solution,  induced  very  high  initial 
rates  of  secretion  that  were  maintained  for  only  a  few 
minutes, subsiding to very low levels within 20 min. In these 
preparations, nerve terminals were swollen and depleted of 
synaptic vesicles; measurements by fluctuation analysis re- 
vealed that the total number of quanta secreted roughly cor- 
responded to previous estimates of the quantal store (Hai- 
mann et al.,  1985; Fesce et al.,  1986) and to the estimated 
average number of synaptic vesicles present in resting frog 
neuromuscular junctions (Segal et al., 1985; Haimann et al., 
1985; Ceccarelli et al., 1988). These results indicate that re- 
cycling  of  synaptic  vesicles  and  continuous  secretion  of 
quanta of ACh were blocked and suggest that the synaptic 
vesicle membranes were incorporated into the axolemma. 
When antisera to frog synaptophysin were used to stain these 
preparations, fluorescent nerve terminal branching was re- 
vealed even without previous permeabilization with deter- 
gent. This finding is in agreement with previous findings by 
von Wedel et al. (1981), who showed that a polyspecific an- 
tiserum to elasmobranch synaptic vesicles bound to exhaus- 
tively stimulated intact frog nerve terminals. It is very un- 
likely that our finding is due to penetration of antibodies 
through an  axolemma damaged  by  exposure to  ct-LTx  in 
Ca2+-free  medium.  In  fact,  ¢t-LTx is  known  to  exert  its 
effects by interacting with a high affinity receptor localized 
in the axolemma (Meldolesi, 1982; Valtorta et al., 1984) and 
it  is  devoid  of proteolytic  and  phospholipolytic  activity 
(Frontali et al.,  1976).  Furthermore, after 1 h of exposure 
to ct-LTx in Ca2+-free medium, the muscle fiber retains its 
normal resting potential indicating that the toxin does not 
produce unspecific permeabilization of membranes.  Patch- 
clamp experiments have shown that ¢t-LTx causes the open- 
ing of small cation channels with a conductance of 15 pS 
(Wanke et al.,  1986) corresponding to a calculated pore ra- 
dius <0.5 nm (Hille, 1984). The present experiments show 
that in ¢t-LTx-treated preparations, the axolemma is not per- 
meable to macromolecules such as horseradish peroxidase 
and myoglobin (Mr 40,000 and  17,000, respectively). It is 
therefore very unlikely that larger molecules like antibodies 
could penetrate into these terminals. 
These results provide strong evidence that synaptophysin 
is incorporated into the axolemma of the swollen terminal 
and that, as a result of vesicle fusion, some intravesicular an- 
tigenic  determinants become exposed to the  extracellular 
space. Previous findings have shown that the most antigenic 
portions of mammalian  synaptophysin are exposed on the 
outer (cytoplasmic) surface of synaptic vesicles (Jahn et al., 
1985).  However, based on the amino acid sequences pre- 
dicted from rat and human cDNA and genomic clones, syn- 
aptophysin appears to have two intravesicular domains (Sued- 
hof et al.,  1987; Buckley et al.,  1987; Leube et al.,  1987). 
The results  reported here show  that  the  anti-frog  synap- 
tophysin antisera recognize intravesicular epitopes. 
The same concentration of ct-LTx,  when applied in the 
presence  of extracellular  calcium,  induced  high  rates  of 
secretion that were maintained throughout the entire hour of 
exposure to the toxin. After this period, a total of nearly two 
million  quanta  had  been  secreted.  This  figure  represents 
more than two times the initial quantal store. These termi- 
nals, which were still secreting at a high steady rate, retained 
their complement of synaptic vesicles and no swelling of the 
terminal  was  evident.  When  horseradish  peroxidase  was 
present in the medium, many of the vesicles appeared to be 
loaded with the tracer. Thus, this multiple quantal turnover 
was maintained by an active recycling process. Under these 
conditions, no synaptophysin immunostaining could be de- 
tected unless plasma membranes had been previously per- 
meabilized with detergent.  In permeabilized preparations, 
the pattern of fluorescence was similar to that observed in 
preparations fixed at rest. These results indicate that, in spite 
of active membrane recycling, the bulk of synaptophysin was 
still  confined within  the axoplasm,  suggesting  that mem- 
brane  retrieval  was  selective for the  vesicle components, 
without detectable intermixing between the two membranes. 
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